FDA advisers back Novavax COVID-19 shots as new US option
42 across the spectrum. Choose a side on the bar to jump to it.
National story. 100 articles from 43 sources. 42 are on the bar; 1 is an international, entertainment or tech outlet, listed separately. Updated Jun 8, 2022.
How each side is putting it
Left
13 sourcesRan by 3 outlets across the spectrum· NPR, New Hampshire Public Radio
Ran by 2 outlets· New Hampshire Public Radio, Wyoming Public Media
Ran by 8 outlets across the spectrum· Minneapolis Star Tribune, Tucson, +2 more
Center
23 sourcesRan by 7 outlets· NBC 6 South Florida, NBC 5 Dallas-Fort Worth, +5 more
Ran by 11 outlets· KTVB Boise, Thv11, +9 more
Ran by 8 outlets across the spectrum· The Buffalo News, WNYT Albany, +2 more
Right
6 sourcesFDA advisers back Novavax COVID shots as 4th US option
Novavax COVID-19 vaccine recommended for approval by FDA advisory committee
Other outlets
International, entertainment and tech outlets, by their rating. Not counted in the bar above. How we count coverage
Left
1 articleCenter
0 articlesNone
Right
0 articlesNone
The story so far
3 developments- Jun 2, 2022New COVID-19 vaccine option Novavax hopes to win over FDA, Americans
- Jun 4, 2022FDA advisers to weigh risks and benefits of Novavax's Covid-19 vaccine
- Jun 7, 2022FDA advisers back Novavax COVID shots as 4th US option
Who covered each development
Left
Center
Right
No new developments
Quiet for 1593 daysLast development · Jun 7, 2022 — FDA advisers back Novavax COVID shots as 4th US option